Lv4
490 积分 2023-09-16 加入
Lenvatinib plus pembrolizumab versus lenvatinib plus placebo for advanced hepatocellular carcinoma (LEAP-002): a randomised, double-blind, phase 3 trial
6小时前
已完结
Transarterial chemoembolisation combined with lenvatinib plus pembrolizumab versus dual placebo for unresectable, non-metastatic hepatocellular carcinoma (LEAP-012): a multicentre, randomised, double-blind, phase 3 study
6小时前
已完结
Global trends in hepatocellular carcinoma epidemiology: implications for screening, prevention and therapy
2个月前
已完结
The treatment of intermediate stage tumours beyond TACE: From surgery to systemic therapy
2个月前
已完结
Subclassification of BCLC B Stage Hepatocellular Carcinoma and Treatment Strategies: Proposal of Modified Bolondi's Subclassification (Kinki Criteria)
2个月前
已完结
Intermediate-stage (BCLC stage B) infiltrative hepatocellular carcinoma: safety and efficacy of chemoembolization
2个月前
已完结
Transarterial Chemoembolization (TACE) Combined with Lenvatinib versus TACE Alone in Intermediate-Stage Hepatocellular Carcinoma Patients Beyond Up-To-Seven Criteria: A Retrospective, Propensity Score-Matched Analysis
2个月前
已完结
Development and validation of the NTAA prognostic model for BCLC stage B hepatocellular carcinoma undergoing transarterial chemoembolization: a retrospective multicenter cohort study
2个月前
已完结
Minimally invasive versus Open liver resection for nonmetastatic Hepatocellular Carcinoma staged BCLC - B and - C: an Italian multicentric analysis
2个月前
已关闭
Postoperative infectious complications following laparoscopic versus open hepatectomy for hepatocellular carcinoma: a multicenter propensity score analysis of 3876 patients
3个月前
已完结
皖公网安备34019202002308
